HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 64 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,200,000 | – | 100,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 421,140 | $5,075,000 | 10.46% |
| Capital International, Inc./CA/ | 4,151,900 | $52,480,000 | 0.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 859 | $68,000,000 | 0.71% |
| GENERAL ATLANTIC, L.P. | 4,000,000 | $50,560,000 | 0.66% |
| Capital International Sarl | 544,653 | $6,884,000 | 0.55% |
| M&G INVESTMENT MANAGEMENT LTD | 6,977,228 | $90,704,000 | 0.54% |
| E Fund Management (Hong Kong) Co., Ltd. | 58,861 | $744,000 | 0.51% |
| Bellevue Group AG | 1,756,307 | $21,359,000 | 0.30% |
| AIA Group Ltd | 356,640 | $4,508,000 | 0.24% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 224,634 | $2,839,000 | 0.11% |